QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT) 会议论文 作者:  Woo, H.;  Fizaz, K.;  Sulur, G.;  Tran, N.;  Fein, L. 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05 Management of patients with advanced prostate cancer in the Asia Pacific region: "real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 期刊论文 BJU INTERNATIONAL, 2019, 卷号: 123, 期号: 1 作者:  Chiong, Edmund;  Murphy, Declan G.;  Akaza, Hideyuki;  Buchan, Nicholas C.;  Chung, Byung Ha 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 advanced prostate cancer  castration-naive prostate cancer  castration-resistant prostate cancer  high-risk localised prostate cancer  oligometastatic prostate cancer  cost and access to treatment   Clinical activity of abiraterone plus prednisone in docetaxel-naive and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer 期刊论文 ASIAN JOURNAL OF ANDROLOGY, 2019, 卷号: 21, 期号: 2 作者:  Lin, Guo-Wen;  Li, Gao-Xiang;  Dai, Bo;  Ye, Ding-Wei;  Kong, Yun-Yi 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 abiraterone acetate  castration-resistant prostate cancer  clinical activity  docetaxel-naive  docetaxel-pretreated   A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy naive patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文 ASIAN JOURNAL OF UROLOGY, 2017, 卷号: 4, 期号: 2 作者:  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji;  Matveev, Vsevolod 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Abiraterone  Chemotherapy-naive  Metastatic castration-resistant prostate cancer  Prostate specific antigen  Prednisone   Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study 会议论文 作者:  Ahn, H.;  Ye, D.;  Pu, Y-S.;  Han, W.;  Xie, L-P. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study 会议论文 作者:  Ye, D.;  Ahn, H.;  Pu, Y-S.;  Weiqing, H.;  Xie, L-P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, 会议论文 BJU INTERNATIONAL, 2015-08-01 作者:  Sun, Yinghao;  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, 期刊论文 2015, 卷号: 116, 期号: ,SI, 页码: 2-2 作者:  Sun, Yinghao;  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji 收藏  |  浏览/下载：13/0  |  提交时间：2020/01/13